Progress in the Chemistry of Organic Natural Products 102 [E-Book] / edited by A. Douglas Kinghorn, Heinz Falk, Simon Gibbons, Jun'ichi Kobayashi.
Falk, Heinz, (editor)
Gibbons, Simon, (editor) / Kinghorn, A. Douglas, (editor) / Kobayashi, Jun'ichi, (editor)
Cham : Springer, 2016
V, 252 p. 190 illus., 10 illus. in color. online resource.
englisch
9783319331720
10.1007/978-3-319-33172-0
Progress in the Chemistry of Organic Natural Products ; 102
Full Text
LEADER 02469nam a22003975i 4500
001 978-3-319-33172-0
003 Springer
008 160705s2016 gw | s |||| 0|eng d
020 |a 9783319331720 
024 7 |a 10.1007/978-3-319-33172-0  |2 doi 
035 |a (Sirsi) a614235 
041 |a eng 
082 0 4 |a 547  |2 23 
245 1 0 |a Progress in the Chemistry of Organic Natural Products 102  |h [E-Book] /  |c edited by A. Douglas Kinghorn, Heinz Falk, Simon Gibbons, Jun'ichi Kobayashi. 
264 1 |a Cham :  |b Springer,  |c 2016  |e (Springer LINK) 
300 |a V, 252 p. 190 illus., 10 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 |a Progress in the Chemistry of Organic Natural Products ;  |v 102 
500 |a englisch 
520 |a The first contribution reviews the phytochemical, chemical, and biological literature on members of the ingenane class of diterpenoids from their first isolation in 1968 through 2015, highlighting unresolved issues both common to phorboids and specific to ingenol derivatives. The biogenesis of ingenol is discussed in the light of the Jakupovic proposal of a dissection between the formation of the macrocyclic Euphorbia diterpenoids and the phorboids, and the clinical development of ingenol mebutate is chronicled in the light of its “reverse-pharmacology” focus. The second contribution offers a comprehensive view of the chemical wealth and the taxonomic problems currently impeding chemical and biological investigations of the genus Laurencia. It addresses the botanical description and the growth and population dynamics of the genus, as well as its chemical diversity and ecological relations; the secondary metabolites as well as their sources of isolation; and finally the biological activity. 
650 0 |a Chemistry. 
650 0 |a Medical biochemistry. 
650 0 |a Medicinal chemistry. 
650 0 |a Organic chemistry. 
700 1 |a Falk, Heinz,  |e editor 
700 1 |a Gibbons, Simon,  |e editor 
700 1 |a Kinghorn, A. Douglas,  |e editor 
700 1 |a Kobayashi, Jun'ichi,  |e editor 
856 4 0 |u http://dx.doi.org/10.1007/978-3-319-33172-0  |z Volltext 
915 |a zzwFZJ3 
932 |a Chemistry and Materials Science (Springer-11644) 
596 |a 1 
949 |a XX(614235.1)  |w AUTO  |c 1  |i 614235-1001  |l ELECTRONIC  |m ZB  |r N  |s Y  |t E-BOOK  |u 3/8/2016  |x ZB-C  |z UNKNOWN  |0 NEL  |1 ONLINE